WebMar 14, 2024 · Funding Program between Oxurion and Negma Ends Funding Program between Oxurion and Negma Ends Leuven, BELGIUM, Boston, MA, US – March 2, 2024 8:00 am CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in … WebStock OXURION Common Stock BE0003846632 XBRU Euronext Brussels Live Euronext kurser, quotes, realtime prices, charts, grafieken, bedrijfsnieuws, AEX BEL Beurs OXURION …
Philip Corens Pinchart - Antwerp, Flemish Region, Belgium
WebNov 4, 2024 · Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to … WebApr 12, 2024 · Keukenrol schreef op 12 april 2024 09:15:. Zolang ze gebruik maken van de korting creëren ze waarde voor de aandeelhouders. Een daling van 4% op dit nieuws is puur, omdat het aandeel tencent met 4,5% daalde. does brene brown go to church
Oxurion Receives Transparency Notification from Atlas Special ...
WebMar 20, 2024 · Oxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas Special Opportunities LL. PDF Version. March 14, 2024 Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema and Announces Board Changes . EN. WebOxurion verhoogt kapitaal met 500.000 euro. Negma Group Investment heeft 200 converteerbare obligaties omgezet in aandelen Oxurion. Dit werd vanmorgen … WebJun 30, 2024 · Oxurion is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and … eyeworks castlemaine